Ampicillin
Inquiry
| Post Date: | Dec 28,2016 |
| Expiry Date: | Jun 26,2017 |
| Detailed Description: | Cas No. :69-53-4 |
| CAS Registry Number: | 69-53-4 |
| Synonyms: | ;(2S,5R,6R)-6-[(R)-2-Amino-2-phenylacetamido]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid;4-Thia-1-azabicyclo[3.2.0] heptane-2-carboxylic acid, 6-[(aminophenylacetyl)amino]-3,3-dimethyl-7-oxo-, [2S-[2alpha, 5alpha, 6beta(S*)]]-;6-[(Aminophenylacetyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0] heptane-2-carboxylic acid;6-[D(-)-alpha-aminophenylacetamido]penicillanic acid;Adobacillin;Alpen;Amblosin;Amfipen;amino]-3,3,-dimethyl-7-oxo-4-thia-1-azabicyclo;Aminobenzylpenicillin;Amipenix;Amipenix S;Ampi-Bol;Ampicillin A;Ampicillin Sulbactam;Ampicin;Ampicina;Ampicyn;Ampilar;Ampimed;Ampipenin;Ampi-Tablinen;Amplisom;Amplital;Ampy-Penyl;Austrapen;Binotal;Bonapicillin;Britacil;Copharcilin;D(-)-alpha-aminobenzylpenicillin;D(-)-aplha-aminobenzylpenicillin;Doktacillin;Grampenil;Guicitrina;Marisilan;Nuvapen;Omnipen;Pen-Bristol;Penbritin;Penbrock;Penicline;Penstabil;Pentrex;Pentrexyl;Polycillin;Ponecil;QI Damp;Rosampline;Synpenin;Tokiocillin;Totacillin;Totalciclina;Totapen;Ultrabion;Unasyn;Viccillin;Wymox;Ampicillin anhydrous; |
| Molecular Formula: | C16H19N3O4S |
| Molecular Weight: | 349.4 |
| Molecular Structure: | 
|
| Hazard Symbols: |  Xn:Harmful; |
| Risk Codes: | R36/37/38:; R42/43:; |
| Safety Description: | S22:; S26:; S36/37:; |
| Company: | Shanxi Jinjin Chemical Co., Ltd [ China ] |
| Contact: | Lihu Wang |
| Tel: | 0574-89219601 |
| Fax: | 0574-88220444 |
| Email: | sales3@jinjingroup.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
